INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo TERINE (nasal drops)

SCHEDULING STATUS:
S1

PROPRIETARY NAME
(and dosage form):

TERINE (nasal drops)

COMPOSITION:
Phenylephrine Hydrochloride 0.25%
Naphazoline Nitrate 0.025%
Chlorbutol 0.5%

PHARMACOLOGICAL CLASSIFICATION:
A.16.1 Nasal Decongestants.

PHARMACOLOGICAL ACTION:
Nasal decongestant.

INDICATIONS:
Common cold, allergic rhinitis, and sinusitis.

CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients.
If any allergic reactions should occur, discontinue use and consult your doctor.

WARNINGS:
Do not use continuously for periods longer than 7 days.

DOSAGE AND DIRECTIONS FOR USE:
Adults: Instil 2 to 4 drops into each nostril, every four hours.
Children over 5 years: 2 drops into each nostril every four hours.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
None when used as directed. Do not use continuously for periods longer than 7 days.

KNOWN SYMPTOMS OF OVER DOSAGE AND PARTICULARS OF ITS TREATMENT:
None known. Not to be taken orally.

IDENTIFICATION:
A clear colourless solution.

PRESENTATION:
10 mL, 15 mL and 20 mL White dropper bottle with a white screw cap.

STORAGE INSTRUCTIONS:
Store below 25ºC in well closed containers. KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
H 1546 (Act 101 of 1965)

NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION:
Gulf Drug Company (Pty) Ltd.
22 Burnside Drive
Old Mill Industrial Park
Mount Edgecombe, 4300

www.gulfdrug.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
26 February 1975

New addition to this site: July 2010
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2010